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Malabsorption in Infants with Congenital Heart 
Disease under Diuretic Treatment 
NACHUM VAISMAN, TIRZAH LEIGH, HILLARY VOET, KLAAS WESTERTERP, 
MATITIAU ABRAHAM, AND ROLAND DUCHAN 
Pediatrics Department, Kaplan Hospital, Rehovot, Israel [N. K, M.A.]; Faculty of Agriculture, 
Rehovot, Israel [T. L., H. K 1; The Soreq Nuclear Research Center, Yavne, Israel [R. D. ]; and 
Department of Human Biology, University of Limburg, Maastricht, The Netherlands [K. W.] 
Intestinal absorption and its relationship to increased 
total body water was studied in seven infants with congen- 
ital heart disease receiving regular diuretics due to conges- 
tive heart failure. All infants and six age-matched healthy 
controls were studied for a 3-d period during which time all 
food intake was recorded, stools were collected, and total 
body water content (TBW) and extracellular water were 
measured. All the anthropometric measurements were 
lower in the infants with congenital heart disease compared 
with healthy controls. Energy and fat excretion in the 
stools were significantly increased in the group of patients, 
but when expressed as a percentage of daily caloric intake 
or as a percentage of the specific intake (e.g. fat excretion1 
fat intake x 100). no statistical differences were found. 
TBW as a percentage of body weight was increased in our 
patients compared with our controls (84.95 + 5.82% versus 
68.65 .t 4.60%;~ = 0.01) and so was extracellular water as 
a percentage of predicted (200.0 2 18.6% versus 100.9 .t 
Failure to thrive is commonly observed in infants with 
CHD (1,2). Different causes have been suggested to play a 
role in this process, among which are poor caloric intake, 
increased energy expenditure, and intestinal malabsorption 
due to intestinal congestion (3). Some patients with CHD fail 
to gain weight or  gain weight insufficiently, in spite of in- 
creased energy intake. The question then arises whether one 
should further increase their energy intake or  should look for 
other causes involved in this process, such as increased 
malabsorption due to increased caloric content or  malab- 
sorption due to congested intestinal wall. 
The present study was designed to study intestinal 
absorption in infants with CHD who are on diuretic 
treatment due t o  previous status of congestive heart 
failure and t o  try to  correlate intestinal malabsorption 
with different degrees of increased body water content 
and different caloric intakes. Increased water content, 
Received October 21. 1993; accepted April 21, 1994. 
Correspondence: Nachum Vaisman. M.D.. Kaplan Hospital. Pediatrics Depart- 
ment B. Rehovot 76100, Israel. 
7.2%; p = 0.001). A positive correlation was found be- 
tween energy and fat excretion as a percentage of the 
intake and TBW as a percentage of predicted; energy and 
fat malabsorption did not exceed 8% in the patients with 
the highest body water content (120% of predicted). It is 
concluded that malabsorption is not a significant factor in 
failure to thrive of patients with congenital heart disease 
who are receiving regular diuretics. Based on the signifi- 
cant negative correlation between excess body water and 
fat and calorie absorption, however, it is suggested to 
monitor TBW in patients who fail to gain weight. (Pediatr 
Res 36: 545-549,1994) 
Abbreviations 
CHD, congenital heart disease 
TBW, total body water content 
ECW, extracellular water 
reflected by increased TBW and ECW in patients with 
significant intestinal malabsorption, may indicate a pos- 
sible relationship between these parameters. 
METHODS 
The study population consisted of seven infants with 
CHD and six age-matched normal controls. Patients' 
characteristics are given in Table 1. Each patient was  
evaluated in the past by a pediatric cardiologist (M.A.) 
for the degree of his o r  her congestive heart failure. 
Clinical diagnosis of heart failure was based on clinical 
parameters such a s  tachypnea, hepatomegaly, and en- 
larged heart silhouette on radiologic examination. Respi- 
ratory causes of the aforementioned were excluded. 
Most of the patients who were catheterized had a low 
cardiac index, based on Fick equations. All our  patients 
were receiving regular diuretics and digoxin treatment 
and were clinically stable during the study period. All our 
controls were healthy, normal infants with no  CHD who 
were recruited from the hospital personnel. 
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Table 1. Patients' characteristics* 
Age Weight Height HDcirc 
No. Sex (mo) (kg) (cm) WFH% (cm) Diagnosis CHF 
Patients 
1 M 3 5.05 58 93.52 38 DORV, mitral atresia Mild 
hypoplastic LV 
2 F 5.5 6.6 68 85.71 42 Large PDA Mild 
3 M 5 4.8 64 69.57 39 AV-canal, Down's Moderate 
4 M 3.5 3.75 55.5 75.00 38.5 VSD, ASD, PDA Moderate 
5 M 2.5 3.5 55 77.17 38 VSD, COA Moderate 
6 M 4 4.5 59 78.95 40.5 DORV, VSD, TGA Severe-moderate 
7 F 1.5 3.255 52 83.46 32 AV-canal, Down's Severe 
Mean 3.57 4.50 58.80 80.48 38.29 
2 1  SD 21.40 21-14 2 5.54 57.84 23.13 
Controls 
Mean 4.25 6.45 64.0 94.85 42.42 
21 SD 1.84 0.93 2.45 4.96 2.62 
p value between NS 0.007 NS 0.003 0.03 
groups 
WFH%, percentage of ideal weight for height; HDcirc, head circumference; CHF, chronic heart failure; M, male; F, female; DORV, 
double-outlet right ventricle; LV, left ventricle; AV-canal, atrioventricular canal; VSD, ventricular septal defect; ASD, atrial septal defect; PDA, 
patent ductus arteriosus; COA, coarction of the aorta; TGA, transposition of the great vessels. 
The study was approved by the Human Subject Review 
Committee, the Kaplan Hospital, Rehovot, and informed 
consent was obtained from the parents before the study. 
Study &sign. AU infants were studied for a 3-d balance 
period during which time all food intake was recorded, stools 
were collected, and TBW was measured. Patients were ad- 
mitted to the pediatric ward 24 h before commencing the 
study. Patients stayed on their regular diet, and no attempt 
was made to increase food intake during the study time. 
None of the infants were fully tube fed. Weight, height, and 
head circumference were recorded, and weight as a percent- 
age of ideal weight for height was calculated (4). 
Food intake. Food intake was recorded by weighing bottles 
before and after feedings using electronic scales (Keter, 
Rehovot, Israel) to 0.2 g accuracy. Losses by emesis were 
estimated by weighing and were subtracted from the total 
intake. The caloric content of the infant formula was deter- 
mined by bomb calorimeter, nitrogen content by micro- 
Kjeldhal technique, and fat content gravirnetrically. 
Srool coUection. Infants were placed on a metabolic 
frame from which stools were collected. The beginning 
and end of each collection period were marked by admin- 
istering active charcoal to the morning feed on d 1 and 4. 
Stools were weighed at the end of each collection period 
and stored at -20°C for further analysis. A sample was 
taken for a,-antitrypsin analysis (5). 
MetbboZic balance. Energy content of the formulas and 
stools was analyzed by using a bomb calorimeter (Parr, 
Adiabatic Calorimetry, Moline, IL). Nitrogen was ana- 
lyzed using micro-Kjeldahl digestion and an automated 
phenate-hypochlorite method (6 ) ,  and fat was determined 
gravimetrically after acid hydrolysis (7). 
Energy absorption was calculated as the difference 
between daily intake and daily output (stools) and ex- 
pressed as a percentage of energy intake. Fat and protein 
absorptions were expressed as a percentage of total en- 
ergy intake as well as a percentage of the specific intake 
(e.g. protein excretionlprotein intake x 100). 
TBWand ECWmeasurements. TBW was determined by 
deuterium oxide (0.1 glkg body weight) 99.8% enrich- 
ment (Cambridge Isotope Laboratories, Woburn, MA). 
The isotope was administered nasogastrically on the sec- 
ond day of the experiment at least 2 h after the last meal. 
The next meal was postponed until the end of the study. 
Heparinized blood samples were drawn before isotope 
administration and 3 h later. 
TBW was calculated from the isotope dilution *H/H in 
each plasma sample (8). Deuterium concentration in 
background and 3-h blood samples was determined with 
an Aqua-Sira mass spectrometer (VG Isogas Ltd., Mid- 
dlewich, UK). ECW was calculated from the corrected 
bromide space (NaBr 3%, 1 mUkg), as previously de- 
scribed (9). Bromide concentrations were analyzed by 
neutron activation. This procedure measures the concen- 
tration of bromide ( " ~ r )  produced by irradiating the 
naturally occurring stable isotope of bromide, " ~ r ,  with 
thermal neutrons using the Slowpoke reactor (Israel Re- 
search Reactor). The half-life of " ~ r  is 35.4 h. Samples 
were irradiated at a flux of 5 x 10" neutrons/cm2/s. The 
decaying of " ~ r  gamma rays were counted by using a 
100-mL Ge(Li) detector (Seforad, Migdal Haemek, Is- 
rael) coupled with a Tennelec TC 242 amplifier (Oxford 
Instruments, Inc., Oak Ridge, TN) and a multichannel 
analyzer (Ortec CE A63, Oxford Instruments, Inc.). 
Gamma ray intensities were calculated by averaging the 
regions of interest at the positions of 544 and 777 keV 
gamma ray peaks. The intensities were then coupled with 
the appropriate average specific activity obtained by an- 
alyzing standard samples of bromide in the plasma. Cor- 
rected bromide space (CBS) was calculated using the 
following formula: CBS = Br dose/Br plasma x 0.90 x 
0.95 x 0.94, in which 0.90 is the correction for nonextra- 
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cellular distribution, 0.95 is the Donnan equilibrium fac- 
tor, and 0.94 is the correction of water in the plasma, 
which is 0.94%. 
The predicted values for TBW and ECW were derived 
from Cheek's equations (10) and expressed as TBW as a 
percentage of predicted and ECW as a percentage of 
predicted. 
Statistics. The two groups were compared by the un- 
paired t test for the different parameters. Pearson corre- 
lation coefficients were used to correlate the different 
parameters and partial correlation coefficients between 
two parameters while keeping a third relevant parameter 
constant. Results were expressed as mean + 1 SD. 
RESULTS 
All the anthropometric measurements were lower in 
the group of infants with CHD compared with our normal 
controls (Table 1). 
No significant statistical difference was found in the 
energy, fat, or protein intakes of our patients compared 
with our normal control group, expressed per daily intake 
(Table 2). 
Energy and fat excretion in the stools was significantly 
increased, in absolute numbers, in our group of patients 
compared with our normal controls (Table 2). However, 
when expressed as a percentage of daily caloric intake or 
as a percentage of the specific intake (e.g. fat excretion1 
fat intake x loo), no statistical differences were found in 
the excretion of the different substrates (Table 3). a,- 
Antitrypsin excretion was not different in our patients 
compared with our normal controls. 
TBW was increased in our patients compared with our 
normal controls but did not reach significance as a per- 
centage of the predicted values (110.4 k 8.5% versus 97.1 
k 3.98%,p = 0.08) (Table 3). A significant difference was 
found in ECW as a percentage of predicted (200.0 + 
18.6% versus 100.9 2 7.2%,p < 0.001). 
Table 2. Total energy, fat, and protein intake and excretion 
(mean 2 I SD) 
Significance 
CHD group Controls of difference 
Total intake* 
Energy (kcal) 155.6 2 72.5 105.5 + 38.3 NS 
Protein (g) 2.3 + 0.43 2.6 2 0.86 NS 
Fat (g) 6.7 + 2.6 4.6 2 2.1 NS 
Total excretion* 
Energy (kcal) 5.2 2 1.3 3.1 + 1.1 0.01 
Protein (g) 0.19 + 0.08 0.15 k 0.06 NS 
Fat (g) 0.25 + 0.06 0.14 k 0.06 0.01 
As a % of caloric intake 
kcal/kcal% 3.90 2 1.78 2.95 = 0.80 NS 
Fat/kcal% 1.79 * 0.87 1.22 + 0.32 NS 
Proteinlkcal% 0.64 + 0.45 0.59 2 0.25 NS 
As a % of specific intake 
FaVfat% 4.59 + 2.36 3.36 2 1.23 N S  
Protein/protein% 8.68 2 4.23 5.90 k 2.09 NS 
a,-Antitrypsin 1.15 2 1.0 0.71 2 0.22 NS 
(mglg feces) 
Units are per kg body weight per day. 
Table 3. TB W, TB W as a percentage of body weight (TB W%), 
TB W as a percentage of predicted (TBWP%), ECW, and 
ECW as a percentage of predicted (ECWP%) 









CHD group Controls of difference 
3.7 2 0.9 4.9 2 0.2 p = 0.01 
84.95 + 5.82 68.65 -c 4.60 p = 0.01 
110.41 + 8.50 97.05 + 3.98 p = 0.08 
3.2 2 0.8 2.2 + 0.4 p = 0.01 
200.0 2 18.6 100.9 + 7.2 p = 0.001 
When fat excretion as a percentage of fat intake and as 
a percentage of energy intake was examined versus TBW 
as a percentage of predicted, a positive correlation was 
found in our sick patients [r = 0.96 (p = 0.002) and r = 
0.82 (p = 0.04), respectively] (Fig. 1). Although this 
points to increased malabsorption when TBW is in excess 
of the predicted, in our sample the maximum fat excre- 
tion as a percentage of fat intake was not higher than 8% 
when TBW was 20% above the predicted value. 
Table 4 demonstrates the correlations between our 
main parameters: energy and fat intake, energy and fat 
absorption, and TBW as a percentage of predicted. Neg- 
ative correlations were found between energy and fat 
intake and the different measurements of malabsorption 
(Fig. 2). After correcting for the effect of TBW on these 
parameters, the partial correlations between total intake 
and energy excretion were r = -0.33 (NS) and r = -0.42 
(NS) for total calorie and fat excretion, respectively. A 
positive correlation was found between excess water 
content and malabsorption. This association persisted 
even after correcting for a possible intake effect, and a 
partial correlation of 0.89 @ = 0.04) was observed. Ex- 
cess water content was negatively correlated with energy 
and fat intake. 
DISCUSSION 
Our results indicate that infants with CHD receiving 
regular diuretics for congestive heart failure do not sig- 
Fat 
Tobl Body Watw o( of Prodotodl 
Figure 1. Fat and energy excretions as a percentage of energy intake. 
as a function of TBW percent of predicted. 
548 VAISMAN ETAL. 
Table 4. Correlations between intake, excretion, and excess 
body water content 
Energy 
TBWPP* intake 
Energy intake r = 0.81 
(p = 0.05) 
Fat intake r = -0.99 r = 0.76 
@ = 0.Oool) @ = 0.05) 
Energy excretionlenergy intake r = 0.91 r = -0.80 
(p = 0.01) (p = 0.03) 
Fat excretionlfat intake r = 0.96 r = -0.79 
(p = 0.002) (p = 0.04) 
TBWPP, TBW as a percentage of predicted. 
nificantly malabsorb. The level of malabsorption is not 
unreasonable for these patients. A tendency toward fat 
malabsorption is seen when TBW is 20% higher than 
predicted, but even then malabsorption is not significant. 
In spite of the small sample size, the 95% confidence 
limits for total caloric excretion/caloric intake are 2.12% 
and 5.68%, indicating, with 95% certainty, that mean 
caloric malabsorption for CHD patients receiving diuret- 
ics is at least 2.12% and at most 5.68%. Fat excretionlfat 
intake values in the sample are all less than 8%, even 
when TBW is 20% above predicted. In addition, the 95% 
confidence limits for the mean are 2.23% and 6.95%, so 
that the highest feasible level for fat malabsorption is also 
not large enough to explain failure to thrive. Very few 
studies have dealt with intestinal malabsorption in pa- 
tients with CHD and congestive heart failure. Our results 
are in accordance with previous studies by Sondheimer 
and Hamilton (11) and Yahav et al. (12). In a similar way, 
Sondheimer and Hamilton found mild abnormalities in 
intestinal absorption that, in contrast to our results, could 
not be related to the type or severity of the cardiac lesion. 
Yahav et al. found minor absorptive abnormalities such 
as mild steatorrhea, bile salt loss, delayed gastric empty- 
ing, and abnormal triglyceride loading tests in their pa- 
Flguc 2. Fat excretion as a percentage of fat intake vs total daily intake. 
tients but also concluded that intestinal malabsorption 
does not seem to cause failure to gain weight in these 
patients. Intestinal losses were not significantly increased 
in our patients, similar to the findings of Sondheimer and 
Hamilton (11) and Iber et al. (13). 
Very few studies have measured water content in patients 
with CHD and congestive heart failure. Mellits and Cheek 
(14) measured TBW and ECW in older patients with CHD. 
In their younger group of patients, less than 137 crn in height, 
no difference was found between patients and normal con- 
trols. Brans et al. (15) determined body water content and 
distriiution in 16 children aged 2 wk to 28 mo before and 
after open-heart surgery for correction of CHD. TBW mea- 
sured by antipyrine space and ECW as measured by the 
corrected bromide space were increased compared with val- 
ues in normal controls. In malnourished patients with kwa- 
shiorkor, TBW and ECW as a percentage of body weight 
were increased, whereas the intracellular water compart- 
ment was contracted (16). Although they were receiving 
regular diuretics, some of our patients had increased TBW 
up to 120% of predicted. 
Increased caloric intake was proved to increase body 
weight in patients with CHD and failure to thrive (17). On 
the other hand, different studies have shown contradic- 
tory results on the role of low caloric intake as a contrib- 
utor to failure to thrive in patients with CHD. In a 
longitudinal study over a 6-mo period, Salzer et al. (18) 
followed 21 infants with CHD with and without cyanotic 
heart and a control group of patients with innocent car- 
diac murmur (18). Weight, length, and combined skinfold 
thickness were significantly lower in the two groups with 
CHD compared with the control group from 183 through 
365 d of age. However, energy and protein intakes were 
similar in the two groups. It was concluded that a low 
level of food intake is not the main cause of inadequate 
growth and inadequate subcutaneous fat stores in infants 
with CDH. Strangway et al. (19) studied the relationship 
between diet and growth in 568 patients with CHD under 
11 y of age. They also concluded that nutrient intake is 
not an important factor limiting their growth. Other stud- 
ies, on the other hand, found that growth failure appears 
to be most appropriately related to inadequate caloric 
intake rather than to other factors studied (20,21). Some 
recent studies have shown that increased food energy 
content, up to 150-160 kcalkg body weightld, is associ- 
ated with increments in length, weight, and subcutaneous 
tissue mass (22). Meeting such high needs may be a 
problem in unstable sick infants, who tend to be anorectic 
and may increase cardiac and respiratory rate during 
feeding (23). It was therefore suggested that feedings 
should be administered to these patients continuously 
over 24 h by nasogastric tube (21, 24). The increase in 
energy content of feedings needed to maintain weight 
gain in these patients is most probably not caused by 
decreased absorption or enteral loss but rather by in- 
creased energy expenditure. The studies that addressed 
this question showed increased oxygen consumption, 
indicating increased energy expenditure (25, 26). 
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To study the interrelationships between the three param- 
eters excess body water, energy intake, and energy ab- 
sorption, a partial correlation analysis was used. A signif- 
icantly positive association was found between excess 
water and malabsorption, whereas the correlation between 
energy intake and malabsorption was nonsignificant. The 
overall correlations between the different parameters indi- 
cate that excess body water content (TBW and ECW) is 
accompanied by increased energy and fat excretion. This 
relationship persists, even after accounting for the effect of 
energy intake on each of the parameters. Indeed, when 
considering the partial correlations, the association be- 
tween energy intake and malabsorption seems to be ex- 
plained by the effect of differences in TBW. Increased 
TBW and ECW by themselves do not ultimately indicate 
that our patients were congested due to relative heart 
failure. Undernutrition, as indicated by reduced weight as 
a percentage of ideal weight for height, is also accompa- 
nied by increased ECW (27). Unfortunately, the only way 
to evaluate lean body mass in this age group, less than 1 y, 
is by measuring TBW. Because we assume that our pa- 
tients suffer from changes in their water compartments, 
this way of evaluation is not valid for this group. Further- 
more, the shift of water in patients receiving daily diuretics 
is not known, and we therefore chose to express our 
results in relation to their TBW. We also believe that the 
lack of correlation between ECW and malabsorption is due 
to this fact. Nevertheless, ECW double that predicted and 
lack of correlation between weight as a percentage of ideal 
weight for height and fat and caloric malabsorption are less 
supportive of this possibility, and a more feasible hypoth- 
esis is that malabsorption is the result of relative conges- 
tion due to insufficient diuretics. 
To prove a causative relationship between congestion 
due to heart failure and malabsorption, one should study 
patients with different degrees of congestion. Such a study 
would be unethical and very difficult to carry out because 
of an unstable clinical situation and changes in water com- 
partments during the study due to diuretic treatment. Our 
patients were all receiving regular diuretics, which mini- 
mized the difference between them and other patients with 
CHD without a congestive component. 
Low levels of energy intake were accompanied by 
increased levels of TBW. We believe that patients with 
excess body water are most probably sicker and there- 
fore consume less, but that increased water content by 
Fat Exoretion 
(% of To ta l  I n t a k d  
Total ''-0.8 1 T o t a l  Body W a t e r  
1% of Pfedloted)  7 
Figure 3. The relationship between caloric intake, excess body water 
content, and energy and fat excretion. 
itself, beyond the possible effect of intake, contributes 
positively to intestinal malabsorption. This relationship is 
best demonstrated in Figure 3. 
Based on the above, we suggest that maintenance of water 
balance is essential for efficient absorption and can improve 
energy absorption for a given amount of energy intake. Our 
study indicates that infants with CHD receiving regular di- 
uretics do not significantly malabsorb and will most probably 
gain weight if their TBW is not extremely expanded. 
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